Treatment of Umbilical Cellulitis
For umbilical cellulitis without purulent drainage or abscess, initiate oral antibiotics targeting streptococci with penicillin, amoxicillin, cephalexin, dicloxacillin, or clindamycin for 5 days, and hospitalize immediately if systemic signs, necrotizing features, or severe immunocompromise are present. 1
Antibiotic Selection Algorithm
First-Line Oral Therapy (Outpatient)
- Penicillin, amoxicillin, cephalexin, or dicloxacillin are preferred for typical umbilical cellulitis targeting streptococci, the primary pathogen 1
- Amoxicillin-clavulanate provides broader coverage and is appropriate for initial empiric therapy 1
- Clindamycin is the preferred alternative for penicillin-allergic patients, with 99.5% susceptibility against streptococci 2
When to Add MRSA Coverage
- MRSA coverage is not routinely indicated for typical umbilical cellulitis 1
- Consider MRSA coverage only if purulent drainage, penetrating trauma, or underlying abscess is present 1
- If MRSA suspected, add vancomycin (inpatient) or oral clindamycin/trimethoprim-sulfamethoxazole 1
Treatment Duration
- 5 days is sufficient if clinical improvement occurs by day 5 1
- Extend beyond 5 days only if improvement has not occurred 1
- This shorter duration is as effective as traditional 10-day courses when response is adequate 1
Critical Distinction: Cellulitis vs. Abscess
- If purulent collection or abscess is present, this is NOT cellulitis—primary treatment is incision and drainage, not antibiotics alone 1
- The term "cellulitis" should not be used for inflammation surrounding a purulent focus 1
- Recurrent umbilical cellulitis may indicate a foreign body (omphalith), urachal remnant, or other structural abnormality requiring surgical intervention 3, 4
Immediate Hospitalization Criteria
Admit for intravenous antibiotics if any of the following are present:
- Systemic signs: fever, tachycardia, hypotension, confusion, or leukocytosis 1
- Necrotizing features: periumbilical ecchymosis, crepitus, bullae, or rapidly spreading necrosis 1, 5
- Severe immunocompromise or neutropenia 1
- Failure of outpatient therapy within 24-48 hours 1
- Concern for deeper infection: intra-abdominal abscess, portal vein thrombophlebitis, peritonitis, or bowel ischemia 1
Neonatal Considerations
- In neonates, umbilical cellulitis (omphalitis) is caused by Staphylococcus aureus, group A and B Streptococci, and Gram-negative bacilli (E. coli, Klebsiella, Pseudomonas) 1
- Neonatal omphalitis can rapidly progress to necrotizing fasciitis with mortality rates up to 13% 1, 5
- Early recognition and aggressive treatment are critical, as patients may appear deceptively well before rapid deterioration within 24-72 hours 5
Diagnostic Testing
- Blood cultures are unnecessary for typical umbilical cellulitis 1
- Obtain blood cultures if systemic features present (high fever, hypotension), malignancy, neutropenia, or severe immunodeficiency 1
- Consider imaging (ultrasound or CT) if recurrent infection, concern for abscess, or suspicion of urachal remnant 4
Adjunctive Measures
- Elevation of the affected area promotes drainage of edema and inflammatory substances, hastening recovery 1
- Identify and treat predisposing factors: poor hygiene, foreign bodies (omphaliths), or anatomic abnormalities 3, 4
Common Pitfalls to Avoid
- Do not empirically cover MRSA in typical umbilical cellulitis without purulent drainage or specific risk factors 1
- Do not use antibiotics alone if an abscess or purulent collection is present—drainage is mandatory 1
- Do not delay hospitalization if necrotizing features or systemic signs are present, as mortality is high without aggressive early intervention 1, 5
- Do not overlook structural abnormalities in recurrent cases—consider foreign body removal or surgical resection of urachal remnants 3, 4